This article has been updated from a previous version that incorrectly referred to ZyGem's microbial fingerprinting technology as molecular fingerprinting.

By Ben Butkus

New Zealand-based ZyGem's acquisition of MicroLab Diagnostics this week is expected to accelerate the company's transformation from a provider of DNA extraction products to a purveyor of fully integrated DNA-testing platforms for the forensics, biodefense, and eventually clinical diagnostics markets, a company official said this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.